Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 29,755 | N/A | N/A | N/A |
| Marketable Securities | 185,997 | N/A | N/A | N/A |
| Receivables | 1,092 | N/A | N/A | N/A |
| Other current assets | 2,925 | 0 | 0 | 0 |
| TOTAL | $220,683 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 688 | N/A | N/A | N/A |
| Other Non-Current Assets | 421 | 0 | 0 | 0 |
| TOTAL | $1,109 | $N/A | $N/A | $N/A |
| Total Assets | $221,792 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,171 | 0 | 0 | 0 |
| Accrued Expenses | 4,380 | N/A | N/A | N/A |
| TOTAL | $6,551 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 157 | 0 | 0 | 0 |
| TOTAL | $157 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,708 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 217,650 | N/A | N/A | N/A |
| Common Shares | 289,482 | N/A | N/A | N/A |
| Retained earnings | -75,955 | N/A | N/A | N/A |
| Other shareholders' equity | 1,557 | 0 | 0 | 0 |
| TOTAL | $215,084 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $221,792 | $0 | $0 | $0 |